115 related articles for article (PubMed ID: 18258233)
21. Loss of cyclin g1 expression in human uterine leiomyoma cells induces apoptosis.
Kwon SH; Park JC; Ramachandran S; Cha SD; Kwon KY; Park JK; Park JW; Bae I; Cho CH
Reprod Sci; 2008 Apr; 15(4):400-10. PubMed ID: 18497347
[TBL] [Abstract][Full Text] [Related]
22. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.
Pan Q; Luo X; Chegini N
Mol Hum Reprod; 2010 Mar; 16(3):215-27. PubMed ID: 19906824
[TBL] [Abstract][Full Text] [Related]
23. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Ngan BY; Forte V; Campisi P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
[TBL] [Abstract][Full Text] [Related]
24. Elk-1, CREB, and MKP-1 regulate Egr-1 expression in gonadotropin-releasing hormone stimulated gonadotrophs.
Mayer SI; Willars GB; Nishida E; Thiel G
J Cell Biochem; 2008 Dec; 105(5):1267-78. PubMed ID: 18814180
[TBL] [Abstract][Full Text] [Related]
25. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of the 14-3-3γ protein in uterine leiomyoma cells results in growth retardation and increased apoptosis.
Shen Q; Hu X; Zhou L; Zou S; Sun LZ; Zhu X
Cell Signal; 2018 May; 45():43-53. PubMed ID: 29382566
[TBL] [Abstract][Full Text] [Related]
27. Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells.
McCarthy-Keith DM; Malik M; Britten J; Segars J; Catherino WH
Fertil Steril; 2011 Jun; 95(7):2383-7. PubMed ID: 21496801
[TBL] [Abstract][Full Text] [Related]
28. The expression of estrogen receptor isoforms alpha, beta and insulin-like growth factor-I in uterine leiomyoma.
Zhao Y; Zhang W; Wang S
Gynecol Endocrinol; 2008 Oct; 24(10):549-54. PubMed ID: 19012097
[TBL] [Abstract][Full Text] [Related]
29. Uterine angioleiomyomas: a report of 3 cases of a distinctive benign leiomyoma variant.
McCluggage WG; Boyde A
Int J Surg Pathol; 2007 Jul; 15(3):262-5. PubMed ID: 17652533
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
[TBL] [Abstract][Full Text] [Related]
31. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
[TBL] [Abstract][Full Text] [Related]
32. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of ATP-sensitive potassium channels for estrogen-mediated cell proliferation in human uterine leiomyoma cells.
Park SH; Ramachandran S; Kwon SH; Cha SD; Seo EW; Bae I; Cho C; Song DK
Gynecol Endocrinol; 2008 May; 24(5):250-6. PubMed ID: 18569028
[TBL] [Abstract][Full Text] [Related]
34. Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity.
Moretti RM; Montagnani Marelli M; Mai S; Limonta P
Int J Oncol; 2008 Aug; 33(2):405-13. PubMed ID: 18636163
[TBL] [Abstract][Full Text] [Related]
35. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
36. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
37. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
[TBL] [Abstract][Full Text] [Related]
38. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial.
Coddington CC; Grow DR; Ahmed MS; Toner JP; Cook E; Diamond MP
Fertil Steril; 2009 May; 91(5):1909-13. PubMed ID: 18439584
[TBL] [Abstract][Full Text] [Related]
39. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.
So WK; Cheng JC; Poon SL; Leung PC
FEBS J; 2008 Nov; 275(22):5496-511. PubMed ID: 18959739
[TBL] [Abstract][Full Text] [Related]
40. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
